Skip to main content
Fig. 5 | Clinical and Translational Medicine

Fig. 5

From: Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma

Fig. 5

Serum S100A6 levels as prognostic biomarker for CCA. a Patients that succumbed to death showed a trend towards higher levels of S100A6 at admission to our hospital when compared to survivors (not significant). b, c Cox regression- and Kaplan–Meyer curve analyses revealed that those patients that displayed high S100A6 levels (e.g. S100A6 levels within the upper quartile of the CCA cohort) had a trend towards an impaired prognosis. d Postoperative S100A6 levels also depicted a trend towards a better survival in patients with low S100A6 concentrations. e, f Kinetics of S100A6 serum concentrations before/after surgery did not indicate the patients’ prognosis

Back to article page